ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000232940.1	Avagacestat	Bladder urothelial carcinoma	0.035618409	Resistant
ENSG00000232940.1	Avagacestat	Head and neck squamous cell carcinoma	0.008518106	Resistant